Summary
Definition
History and exam
Key diagnostic factors
- presence of risk factors
- chronic erosive blistering of the skin, mucosa, or both
- chronic mouth erosions (PV, PNP)
- painful lips (PNP)
- shortness of breath (PNP)
Other diagnostic factors
- pruritic scalp (PV, PF)
- bloody nose (PV, PNP)
- painful skin (PV, PF, PNP)
- dysphagia (PV)
- pruritic skin (PV, PF)
- conjunctivitis (PV, PNP)
Risk factors
- increasing age
- HLA DR4 (PV)
- HLA DQ1 (PV)
- HLA DRB1 (PNP)
- associated malignancy (PNP)
- D-penicillamine
- ACE inhibitors
- penicillin
- thiopronine
- interleukin 2
- nifedipine
- rifampicin
- exposure to haematophagous insects
Diagnostic investigations
1st investigations to order
- skin biopsy, haematoxylin and eosin stain
- skin biopsy, direct immunofluorescence
Investigations to consider
- indirect immunofluorescence on serum
- serum ELISA
- upper gastrointestinal endoscopy
- CXR
- chest CT scan
- PFT
- serum immunoblot (Western blot)
Treatment algorithm
Contributors
Authors
Jon H. Meyerle, MD
Associate Professor
Department of Dermatology
Uniformed Services University of the Health Sciences
Bethesda
MD
Disclosures
JHM declares that he has no competing interests.
Grant J. Anhalt, MD
Professor
Department of Dermatology
Johns Hopkins Medical Institution
Baltimore
MD
Disclosures
GJA is a consultant for Janssen on a clinical trial design for an investigational drug for bullous pemphigoid.
Peer reviewers
Daniel Mimouni, MD
Professor
Department of Dermatology
Rabin Medical Center
Petah Tikva
Israel
Disclosures
DM declares that he has no competing interests.
Vesna Petronic-Rosic, MD, MSc
Associate Professor and Clinical Director
Section of Dermatology
University of Chicago
Chicago
IL
Disclosures
VPR declares that she has no competing interests.
Timothy Patton, MD
Assistant Professor of Dermatology
Department of Dermatology
University of Pittsburgh
Pittsburgh
PA
Disclosures
TP declares that he has no competing interests.
Use of this content is subject to our disclaimer